The US Food and Drug Administration on Thursday approved the first gene therapy for inherited hearing loss, a one-time treatment that proved to be life-changing for a small number of children in a ...
A gene therapy developed with the help of Harvard Medical School researchers restored hearing in 90 percent of patients with ...
As cell and gene therapy leaders gathered in Maryland to discuss accelerating clinical trials in children, one “cutting edge” ...
Urnov is a professor of molecular therapeutics at the University of California, Berkeley, and a director at its Innovative Genomics Institute. In May, news broke of a biomedical first: the on-demand ...
By Kunal Das and Kamal Choudhury April 27 (Reuters) - Intellia Therapeutics said on Monday its experimental gene-editing therapy reduced the frequency of swelling attacks in patients with a rare ...
IFLScience on MSN
First-of-its-kind gene therapy for inherited hearing loss approved by FDA as trial shows improvement in 80 percent of patients
The US Food and Drug Administration (FDA) has just approved the first-ever gene therapy for a form of inherited hearing loss. The one-time treatment targets a gene that’s responsible for 2-8 percent ...
10d
Milestone for Crispr: First-of-Its-Kind Gene Editing Treatment Successfully Passes Clinical Trial
Intellia Therapeutics, a leading biotechnology company, announced that its CRISPR-based treatment for a rare swelling ...
After gene therapy for a rare form of deafness, 90% of participants in a clinical trial in China had significant improvement ...
CLEVELAND — Gene editing is the revolution in medical history and a groundbreaking Cleveland Clinic trial is demonstrating how this technology could transform the way millions of Americans manage high ...
The agency's decision is based on results from a clinical trial in which the treatment improved hearing in 80 percent of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results